LifeActive Bio Announces Commercial Launch, Four Initial Product Lines, and Appointment of World-Renowned Cardiologist as Chief Medical Officer

 

Biotechnology pioneer behind XnanodeX™ Nano-Emulsion opens doors to global licensing and private-label partnerships as it brings pharmaceutical-grade bioavailability to the wellness, beverage, and longevity market.

April 2, 2026

San Francisco, Calif. — April 2, 2026 — LifeActive Bio, the biotechnology company behind the proprietary XnanodeX™ Nano-Emulsion platform, today announced that it is now in revenue, having successfully commercialized four inaugural product lines powered by its breakthrough lipid nanoparticle technology. The company simultaneously announced the appointment of Dr. John Jefferies, MD, MBA, MPH, FACC, FAHA as Chief Medical Officer and confirmed that it is in active negotiations with global brands for new product line launches — with licensing and private-label programs open to qualified partners.

LifeActive Bio’s XnanodeX™ Nano-Emulsion technology forms natural lipid nanoparticles that dramatically improve the absorption and bioavailability of nutritional compounds — addressing one of the most persistent challenges in health and wellness: getting nutrients into the body in a form it can actually use. All formulations are all-natural, hypoallergenic, non-GMO, gluten-free, and developed in compliance with FDA GRAS standards.

Four Product Lines Now in Market

Multi-Active Functional Beverage — Available in four ready-to-market formats (1.5 oz shot, 6 oz, 12 oz, and 16 oz), this clean-label performance drink delivers all nine essential amino acids, BCAAs, a full B-vitamin complex, Vitamins C, D3, and E, folate, nitric oxide precursor pathway support, and a complete electrolyte matrix — all through XnanodeX™ Nano-Emulsion for pharmaceutical-grade bioavailability. Designed for pre- and post-workout use, travel, clinical channels, specialty retail, DTC subscription, and gym-door placement.

Multi-Active Serum for Longevity — A transdermal serum applied directly to skin or used in-shower, formulated to support long-term cellular vitality, healthy aging, metabolic resilience, and reduction of daily stressors. Powered by XnanodeX™ Nano-Emulsion encapsulated for metabolic rejuvenation and pH-optimized for rapid cellular uptake.

Multi-Active Serum for Weight Loss — A clean, stimulant-free metabolic serum delivering targeted amino acids, electrolytes, and vitamins to support metabolic efficiency, nutrient utilization, and healthy body composition goals — without the overstimulation common in conventional weight-management products.

Multi-Active Serums for Hair & Skin — A dual-serum system designed to support hair, skin, and nail rejuvenation through deep, targeted absorption. Formulated with omega-3s, essential amino acids, electrolytes, and nitric oxide precursor pathway support, these serums reset cellular function and boost natural repair and renewal.

All four lines are available for white-label and private-label programs across standard formats, with scalable co-manufacturing and ambient-stable shelf life, enabling DTC, specialty retail, e-commerce, and clinical channel distribution without artificial preservatives.

A Platform Built for Brand Partners

LifeActive Bio is now actively inviting licensing and private-label partnerships with brands at the intersection of wellness, performance, and longevity. The XnanodeX™ Nano-Emulsion platform is designed to empower partners with a scalable, safe, and transformative foundation to launch premium body and longevity-focused products that work in sync with the body’s natural systems, supporting metabolic balance, healthy circulation, rejuvenation, recovery, and lasting cellular resilience.

We built XnanodeX™ Nano-Emulsion to solve a problem that the entire supplement industry had accepted as the status quo — poor bioavailability,” said Dex Morris, Founder, CEO, and Chairman of LifeActive Bio. “The body can only benefit from what it can actually absorb. Our technology changes that equation entirely. Now that we’re in market, we’re focused on extending this platform to global brands who want to lead the next generation of wellness, with science they can stand behind and results their customers will actually feel.

Building and scaling organizations that create real impact is what drives me,” said Tommy Thomasson, President and Co-Founder of LifeActive Bio.LifeActive Bio is positioned at a rare intersection of breakthrough science and massive market demand. The XnanodeX™ Nano-Emulsion platform gives our partners a genuine competitive advantage — and we’ve built the operational foundation to deliver on that promise at scale.”

The company is currently in negotiations with several global brands to co-develop new product lines leveraging the XnanodeX™ platform and is accepting inquiries from interested licensing and private-label partners at info@lifeactivebio.com.

Dr. John Jefferies Appointed Chief Medical Officer

LifeActive Bio has appointed Dr. John Jefferies, MD, MBA, MPH, FACC, FAHA as Chief Medical Officer, bringing world-class clinical leadership to the company’s medical strategy and scientific credibility.

Dr. John Jefferies, MD, MBA, MPH, FACC, FAHA — Chief Medical Officer

Dr. Jefferies is an internationally recognized cardiologist and the Jay M. Sullivan Endowed Chair and Chief of Cardiology at the University of Tennessee Health Science Center (UTHSC). Co-Director of the UT Methodist Institute for Cardiovascular Science and a research member at St. Jude Children’s Research Hospital, Dr. Jefferies is also the team cardiologist for the Memphis Grizzlies. The author of more than 300 peer-reviewed publications and lead editor of two cardiology textbooks, he brings unparalleled clinical rigor to LifeActive Bio’s medical strategy. He holds an MD from UTHSC, an MBA from Wharton, and an MPH from the University of Kentucky, and completed his fellowship at Baylor/Texas Heart Institute.

This appointment joins a founding and leadership team that includes President and Co-Founder Tommy Thomasson — a seasoned business leader with expertise in financial services, retirement plans, technology, and health & wellness, and former co-founder of DailyAccess Corporation, a pioneer in electronic mutual fund trading — as well as Chief Science Officer Scott Jenkins, Ph.D. (formerly of Dell Technologies, IBM, and Apple, and a leading expert in the XnanodeX™ Nano-Emulsion platform), Chief Medical Advisor Dr. Jeffrey Kotzen, MD, FACOG, Chief Operations Officer Lori Brown, Chief Marketing Officer Catherine Oaks, MBA, and Chief Information/Security Officer Mike Jackson.

About LifeActive Bio

LifeActive Bio is a biotechnology company advancing human health, recovery, and vitality through its proprietary XnanodeX™ Nano-Emulsion platform — a technology that forms natural lipid nanoparticles to significantly improve the absorption and bioavailability of nutritional compounds. The company’s clean-label product lines span functional beverages, longevity serums, metabolic formulations, and hair and skin serums — all built on a single, scalable, science-driven delivery platform. LifeActive Bio partners with brands globally through licensing and private-label programs across multiple formats and channels.

Lifeactivebio.com | info@lifeactivebio.com

LifeActive Bio Media Contact

Catherine Oaks

(775) 313-8944
media@lifeactivebio.com

©Copyright 2026.  LifeActive, Inc. DBA LifeActive Bio.   All Rights Reserved.

These statements have not been evaluated by the Food and Drug Administration.  This product is not intended to diagnose, treat, cure, or prevent any disease.